From: Extracellular matrix stiffness regulates colorectal cancer progression via HSF4
Characteristics | All Patients (N = 107) | Low Collagen (N = 50) | High Collagen (N = 57) | P-value |
---|---|---|---|---|
Sex | ||||
Male | 62 | 28 | 34 | 0.85 |
Female | 45 | 22 | 23 | |
Age (year) | 56.92 ± 10.83 | 56.96 ± 12.19 | 56.88 ± 9.58 | 0.97 |
Height (m) | 1.62 ± 0.07 | 1.61 ± 0.08 | 1.62 ± 0.07 | 0.44 |
Weight (kg) | 59.76 ± 11.54 | 57.47 ± 11.32 | 61.76 ± 11.45 | 0.05 |
BMI (kg/m2) | 22.74 ± 3.35 | 22.03 ± 3.30 | 23.35 ± 3.29 | 0.041* |
Stiffness Characteristics | ||||
Shear Wave Velocity of Normal Tissue (m/s) | 1.28 ± 0.13 | 1.27 ± 0.12 | 1.29 ± 0.14 | 0.46 |
Shear Wave Velocity of Tumour Tissue (m/s) | 2.30 ± 0.56 | 2.18 ± 0.46 | 2.41 ± 0.61 | 0.028* |
Ratio of Tumour/Normal | 1.80 ± 0.39 | 1.72 ± 0.31 | 1.88 ± 0.43 | 0.031* |
MRI Characteristics | ||||
mT | ||||
mT1 | 2 | 0 | 2 | 0.041* |
mT2 | 23 | 13 | 10 | |
mT3 | 66 | 34 | 32 | |
mT4 | 16 | 3 | 13 | |
mN | ||||
mN0 | 49 | 24 | 25 | 0.08 |
mN1 | 38 | 21 | 17 | |
mN2 | 20 | 5 | 15 | |
mM | ||||
mM0 | 100 | 48 | 52 | 0.45 |
mM1 | 7 | 2 | 5 | |
Circumferential Resection Margin | ||||
Positive | 15 | 5 | 10 | 0.40 |
Negative | 92 | 45 | 47 | |
Extramural Vascular Invasion; | ||||
Positive | 28 | 8 | 20 | 0.029* |
Negative | 79 | 42 | 37 | |
Tumour Growth Pattern | ||||
Intramural | 32 | 21 | 11 | 0.013* |
Luminal | 64 | 27 | 37 | |
Both | 11 | 2 | 9 | |
Tumour Length (mm) | 43.53 ± 16.72 | 40.62 ± 14.97 | 46.09 ± 17.86 | 0.09 |
Tumour Thickness (mm) | 15.39 ± 7.89 | 13.34 ± 4.98 | 17.19 ± 9.44 | 0.009** |
MRI Cancer Nodule | ||||
Positive | 10 | 3 | 7 | 0.33 |
Negative | 97 | 47 | 50 | |
Hyperintensity on T2w images | ||||
Positive | 14 | 10 | 4 | 0.08 |
Negative | 93 | 40 | 53 | |
Vascular Edema, Necrosis or Mucous Degeneration | ||||
Positive | 20 | 9 | 11 | 1.00 |
Negative | 87 | 41 | 46 | |
Hemorrhage, High T1 | ||||
Positive | 2 | 2 | 0 | 0.21 |
Negative | 105 | 48 | 57 | |
Number of Mesorectal Lymph Nodes | ||||
0 | 48 | 24 | 24 | 0.11 |
1 | 14 | 9 | 5 | |
2 | 22 | 11 | 11 | |
> = 3 | 23 | 6 | 17 | |
Histopathologic features | ||||
pT or ypT | ||||
Tis | 7 | 0 | 7 | 0.06 |
T1 | 10 | 7 | 3 | |
T2 | 24 | 10 | 14 | |
T3 | 63 | 31 | 32 | |
T4 | 3 | 2 | 1 | |
pN or ypN | ||||
N0 | 68 | 30 | 38 | 0.67 |
N1 | 32 | 17 | 15 | |
N2 | 7 | 3 | 4 | |
TNM stage or ypTNM stage | ||||
0 | 7 | 0 | 7 | 0.001** |
I | 16 | 11 | 5 | |
II | 27 | 19 | 8 | |
III | 51 | 18 | 33 | |
IV | 6 | 2 | 4 | |
Cancer Nodule | ||||
Positive | 12 | 5 | 7 | 0.76 |
Negative | 95 | 45 | 50 | |
Perineural Invasion | ||||
Positive | 15 | 6 | 9 | 0.78 |
Negative | 92 | 44 | 48 | |
Vascular Invasion | ||||
Positive | 18 | 9 | 9 | 0.80 |
Negative | 89 | 41 | 48 | |
Histologic Grade | ||||
Low | 13 | 6 | 7 | 0.07 |
Moderate | 82 | 42 | 40 | |
High | 2 | 1 | 1 | |
Unassessable or Missing | 10 | 1 | 9 | |
Mismatch Repair Status | ||||
Deficient Mismatch Repair | 9 | 6 | 3 | 0.20 |
Proficient Mismatch Repair | 76 | 37 | 39 | |
Unassessable or Missing | 22 | 7 | 15 | |
Progression | ||||
Locally advanced rectal cancer | 84 | 39 | 45 | 1.00 |
Non-locally advanced rectal cancer | 23 | 11 | 12 | |
Survival Status | ||||
Alive | 86 | 50 | 57 | 0.027* |
Deceased | 21 | 5 | 16 | |
Average Survival Time (months) | 58.63 ± 1.61 | 60.52 ± 1.34 | 54.63 ± 2.64 | 0.019* |